bioRxivImmunologyPreprint
Human postmortem studies reveal tissue-specific differences amongst TB-patient groups
G. Ahimbisibwe, M. Nakibuule, M. Ssejjoba, D. Oyamo, R. Mulwana, J. Nabulime, F. Babirye, A. Kizito, H. Lekuya, S. Adakun, A. Kyazze, R. Lukande, J. Baluku, I. Biraro, S. Cose
Abstract
If we are to break new grounds in TB research, we need to have a complete understanding of what is occurring at the site of infection in humans. Postmortem studies give us an opportunity to compare TB-involved and -uninvolved tissues, in both diseased and non-diseased individuals. We examined the feasibility of carrying out a postmortem study in Mulago and Kiruddu National Referral Hospitals in Uganda, to determine whether we could use immune cells collected postmortem for immunological studies. We report that we can consent the Next-of-Kin, perform postmortem procedures and process tissues within 8 hours of death, and that immune cells remain viable and functional up to 14 hours after death. We found subtle differences in T cell subsets within TB groups. We found a depletion of the CD4 CD69+CD103+ T cell subset in the lungs and BAL, which was associated with HIV, and that the CD8 CD69+CD103- T cell subset was depleted in BAL only, and was associated with TB. Our data show overall changes Tissue Resident Memory T cells within, and between, TB-infected and TB-uninfected human lungs. SummaryO_LICoroner led postmortem studies are possible in Uganda, samples processed within 8 hours from death C_LIO_LICells from samples collected postmortem are viable and functional C_LIO_LIHIV associated depletion of CD4 CD69+/CD103+ T cell subset in lungs and BAL C_LIO_LICD8 CD69+/CD103- depletion in BAL associated with TB C_LI
- organism: human
- assay: flow cytometry
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Profile of Mycobacterium tuberculosis-specific CD4 T cells at the site of disease and blood in pericardial tuberculosis
E. Du Bruyn, S. Ruzive, … C. Riou·bioRxiv·May 12, 2022
- In-depth immunophenotyping with mass cytometry during TB treatment reveals non-canonical T-cell subsets associated with sputum culture conversion.
C. Chedid, T. Andrieu, … F. Ader·bioRxiv·Oct 27, 2021
- Lung Resident T Cells Across the Spectrum of TB Infection and Disease
Dylan C. Kain, GW McElfresh, … David Michael Lewinsohn·bioRxiv·Aug 17, 2026
- Loss of circulating CD8α+ NK cells during human Mycobacterium tuberculosis infection
Nezar Mehanna, Atul Pradhan, … Charles Kyriakos Vorkas·Scientific ReportsPeer-reviewed·Apr 29, 2025
- Mycobacteria-specific CD4+IFN-γ+ cell expresses naïve-surface markers and confers superior protection against tuberculosis infection compared to central and effector memory CD4+ T cell subsets
S. Chatterjee, J. Yuan, … D. Hoft·bioRxiv·Aug 16, 2018
- Comparative immune responses to Mycobacterium tuberculosis in people with latent infection or sterilizing protection
E. Jalbert, C. Liu, … A. Weinberg·bioRxiv·Jun 13, 2022